Our results showed that MMP-9 (92 and 240 kDa) is significantly increased in the sera from patients with CNS tumors compared to healthy individuals and differences in MMP-9 tissue expression have been underlined between glioblastoma and low-grade glioma specimens. Here, MMP9 is linked to central nervous system cancer.